Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-22
DOI
10.1111/joim.13069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and Outcomes of Non-alcoholic Fatty Liver Disease (NAFLD) among Asian American Adults in the United States
- (2019) Pegah Golabi et al. LIVER INTERNATIONAL
- Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
- (2019) Yeojun Yun et al. PLoS One
- NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter
- (2019) Louise J.M. Alferink et al. JOURNAL OF HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2018) Zobair M. Younossi et al. Clinics in Liver Disease
- Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
- (2018) Donghee Kim et al. HEPATOLOGY
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
- (2018) Elliot B Tapper et al. BMJ-British Medical Journal
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
- (2018) Elliot B Tapper et al. BMJ-British Medical Journal
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
- (2018) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
- (2018) Donghee Kim et al. GASTROENTEROLOGY
- Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease
- (2018) Donghee Kim et al. LIVER INTERNATIONAL
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
- (2017) Michael H. Le et al. PLoS One
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies
- (2016) A. Katrina Loomis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Genetics, diagnostics and therapeutic advances in NAFLD
- (2015) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey
- (2014) C. E. Ruhl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
- (2012) Zobair M. Younossi et al. MEDICINE
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
- (2010) Anna Ludovica Fracanzani et al. JOURNAL OF HEPATOLOGY
- Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
- (2008) Janice Jou et al. SEMINARS IN LIVER DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now